Albert Kim is the CEO and Founder of Greenline POS and a partner for Cannabis + Technology | Retail Tech presented by LeafLink.
His insights into how his retail customers are adapting and shifting in these challenging retail times – using Greenline POS technology – are enlightening.
Visit Cannabis + Technology to learn more.
The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated...
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global...
Event
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated...
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global...
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country's...
As the excitement around President Donald Trump's executive order to push forward with cannabis rescheduling has faded, the bill is...
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of...
Oregon-based edibles company Grön has weighed in on the ongoing controversy surrounding New York’s so-called ‘rent-a-licence’ scandal. The dispute follows...
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow...
Nearly 80% of Canadian’s now source their cannabis solely from the legal market, marking a stark shift away from the...
Australia’s medical cannabis market is thriving, with revenues expected to grow from around US$600m in 2024 to more than US$1.2bn...
A bitter boardroom battle has erupted at MediPharm Labs, one of Canada’s leading pharmaceutical cannabis companies, as investor Apollo Capital...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
